Nasdaq · Surgical & Medical Instruments & Apparatus
18 entities across 17 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2025-08-28 — see the exhibit.
| Entity | Jurisdiction | Note |
|---|---|---|
| Accuray International SARL | Switzerland | |
| Accuray Europe SAS | France | |
| Accuray UK, Ltd. | United Kingdom | |
| Accuray Asia Ltd. | Hong Kong | |
| Accuray Japan K.K. | Japan | |
| Accuray Korea Limited Company | Korea | |
| Accuray Spain, S.L.U. | Spain | |
| Accuray Medical Equipment (India) Private Limited | India | |
| Accuray Medical Equipment (Rus) LLC. | Russia | |
| Accuray Medical Equipment GmbH | Germany | |
| Accuray Medical Equipment (Canada) Ltd. | Canada | |
| Accuray Mexico, S.A. de C.V. | Mexico | |
| Accuray Medical Equipment (Shanghai) Co., Ltd. | China | |
| Accuray Brasil Comércio, Importação e Exportação de Equipamentos Médicos Ltda | Brazil | |
| Accuray Belgium BV | Belgium | |
| Accuray Italy S.R.L | Italy | |
| Accuray Accelerator Technology (Chengdu) Company Limited | China | |
| Accuray LLC | Delaware |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $382.9M | $3.8M | −$5.0M | 39.1% | 90,623,000 |
| FY2021 | $396.3M | −$6.3M | $36.2M | 40.3% | 92,031,000 |
| FY2022 | $429.9M | −$5.3M | −$7.1M | 37.2% | 92,095,000 |
| FY2023 | $447.6M | −$9.3M | $2.9M | 34.4% | 94,884,000 |
| FY2024 | $446.6M | −$15.5M | −$15.5M | 32.0% | 98,272,000 |
| FY2025 | $458.5M | −$1.6M | −$1.4M | 32.1% | 102,768,000 |
9 institutions tracked — 5 added, 4 reduced, 1 sold out. Active managers added 293,486 shares while index money cut 2,239,765.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| STATE STREET CORP | Index | 485,866 | −1,531,787 | $125.3M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 1,189,377 | −1,191,462 | $306.7M |
| VANGUARD GROUP INC | Index | 5,818,576 | +341,899 | $4.8B |
| JPMORGAN CHASE & CO | Active fund | 376,695 | +296,852 | $97.8M |
| BlackRock Finance, Inc. | Index | 8,231,698 | +141,585 | $15.0M |
| FMR LLC | Active fund | 1,375,746 | +86,958 | $354.7M |
| BANK OF AMERICA CORP /DE/ | Active fund | 110,614 | −61,495 | $28.4M |
| MORGAN STANLEY | Active fund | 257,033 | −31,780 | $66.3M |
| CITADEL ADVISORS LLC | Hedge fund | 31,551 | +2,951 | $8.1M |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register. These filings span 2024-Q2–2026-Q2 rather than a single quarter, because filers report on their own schedules.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
ACCURAY INC files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
